Artificial intelligence and machine learning have become the ultimate buzzwords in pharmaceutical marketing. In many instances, companies claim to ...

With recent media attention devoted to privacy breaches, protecting patient data has never been more important to the healthcare industry. Pharmaceutical companies are under pressure to build syste...

 

Gone are the days of relying solely on a primary care physician or specialist to recommend a therapy. Today’s patients are digitally empowered to take control of their diagnostic and treatment jo...

San Francisco (January 7, 2021) – Global health innovation leader W2O today announced it has acquired tech-enabled companies Swoop and IPM.ai, further accelerating what is expected to be its 20th c...

January guidance provided a way for advertisers to determine whether a health segment is non-sensitive or sensitive, and made it a requirement for NAI members using health segments, both non-sensit...

Real World Data increasingly informs the life sciences industry across various functions, for instance in pharmacoeconomic analysis, outcomes research and peak revenue forecasting, but often with a...

Influencing healthcare providers via digital NPI targeting is an important part of any pharmaceutical manufacturer’s marketing strategy, even more than usual with the rise of social distancing. How...

Expands the use of artificial intelligence to positively influence health outcomes without sacrificing patient privacy

Company at the forefront of protecting patient privacy without sacrificing ability to improve health outcomes

Swoop utilizes real world data to uncover precision, privacy-safe segments of ideal patients so that pharmaceutical companies can engage and educate them about new therapiesCAMBRIDGE, MA. – January...